Response to palliative radiotherapy for cancer patients with interstitial lung disease: A physician's perspective

Affiliations

• ¹ Department of Radiology, Nagoya University Graduate School of Medicine, Aichi, Japan; Division of Radiation Oncology and Particle Therapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Chiba, Japan.
• ² Department of Radiation Oncology, National Cancer Center Hospital East, Chiba, Japan; Division of Radiation Oncology and Particle Therapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Chiba, Japan. Electronic address: hhojo@east.ncc.go.jp.
• ³ Department of Radiation Oncology, National Cancer Center Hospital East, Chiba, Japan; Division of Radiation Oncology and Particle Therapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Chiba, Japan.